Please Wait.....
Report
North America Gene Expression Market Report and Forecast 2025-2034
Market Report I 2025-07-29 I 250 Pages I EMR Inc.
North America gene expression market size was valued at USD 2.03 Billion in 2024, driven by the rapid advancement in the field of genomics in the region. The market is expected to grow at a CAGR of 8.50% during the forecast period of 2025-2034, with the values likely to rise from USD 4.59 Billion by 2034.
North America Gene Expression Market Analysis
The market growth is driven by advancements in gene expression analysis, which can help to define tumor subtypes and offer a more targeted approach towards cancer treatment. The rising incidence of cancer coupled with the growing patient inclination towards precision oncology is likely to augment market demand. In 2024, new cancer cases are projected to surpass 2 million in a year in the United States, with the estimates suggesting 5,500 cancer diagnoses in a day and over 611,000 deaths in the year. Insights from gene expression analysis can aid oncologists in providing tailored treatment to the huge patient population, thereby driving North America gene expression market growth.
In December 2023, Neurogene Inc., a United States-based biotechnology company specializing in genetic medicines, concluded a merger deal with Neoleukin Therapeutics, Inc., a biopharmaceutical company creating next-generation immunotherapies. The merged business, expected to hold cash worth USD 200 million on closure, plans to focus on the development of differentiated genetic therapies for the treatment of complex neurological diseases including Rett Syndrome. Such merger and acquisition activities are expected to propel the demand for gene expression analysis tools and services, which is likely to boost the market share in the region.
The market is witnessing technological innovations in DNA-sequencing and array-based technologies, which are anticipated to drive North America gene expression market demand. In March 2023, Illumina Inc., announced the launch of its new Illumina Complete Long Read technology called Illumina Complete Long Read Prep, Human. Designated as the first-ever product that allows access to both long- and short-read data on the same Illumina instrument, it is compatible with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing System. Illumina Complete Long Reads demonstrated accuracy and flexibility, as evidenced by early customer data. The launch of such technologically advanced products which address the limitations associated with long-read technologies and reduce associated costs is likely to support North America gene expression market share in the forecast period.
Other factors that drive the market are the increased application of gene expression profiling in understanding the molecular mechanisms in various diseases, biomarker discovery, drug development, and precision medicine, among others. Moreover, the advancement in healthcare infrastructure and increased investment in research and development are also expected to boost market size.
North America Gene Expression Market Segmentation
North America Gene Expression Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Breakup by Technology
- Polymerase Chain Reaction
- Next Generation Sequencing
- Microarrays
- Northern Blotting
- Others
Breakup by Product Type
- Instruments
- Reagents and Consumables
- Services
Breakup by End User
- Drug Discovery & Development Centers
- Diagnostic Laboratories
- Academic Research Centers
- Others
Breakup by Region
- United States of America
- Canada
North America Gene Expression Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific Inc.
- GE Healthcare
- QIAGEN N.V.
- Life Technologies
- Agilent Technologies
- PerkinElmer
- Bio-Rad Laboratories
- Roche Diagnostics
- Oxford Gene Technology
- Luminex Corporation
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 North America Gene Expression Market Overview
3.1 North America Gene Expression Market Historical Value (2018-2024)
3.2 North America Gene Expression Market Forecast Value (2025-2034)
4 North America Gene Expression Market Landscape*
4.1 North America Gene Expression: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 North America Gene Expression: Product Landscape
4.2.1 Analysis by Technology
4.2.2 Analysis by Product Type
5 North America Gene Expression Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter's Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 North America Gene Expression Market Segmentation (218-2034)
6.1 North America Gene Expression Market (2018-2034) by Technology
6.1.1 Market Overview
6.1.2 Polymerase Chain Reaction
6.1.3 Next Generation Sequencing
6.1.4 Microarrays
6.1.5 Northern Blotting
6.1.6 Others
6.2 North America Gene Expression Market (2018-2034) by Product Type
6.2.1 Market Overview
6.2.2 Instruments
6.2.3 Reagents and Consumables
6.2.4 Services
6.3 North America Gene Expression Market (2018-2034) by End User
6.3.1 Market Overview
6.3.2 Drug Discovery & Development Centers
6.3.3 Diagnostic Laboratories
6.3.4 Academic Research Centers
6.3.5 Others
6.4 North America Gene Expression Market (2018-2034) by Countries
6.4.1 Market Overview
6.4.2 United States of America
6.4.3 Canada
7 United States of America Gene Expression Market (218-2034)
7.1 United States of America Gene Expression Market (2018-2034) by Technology
7.1.1 Market Overview
7.1.2 Polymerase Chain Reaction
7.1.3 Next Generation Sequencing
7.1.4 Microarrays
7.1.5 Northern Blotting
7.1.6 Others
7.2 United states of America Gene Expression Market (2018-2034) by Product Type
7.2.1 Market Overview
7.2.2 Instruments
7.2.3 Reagents and Consumables
7.2.4 Services
7.2.5 Others
7.3 United States of America Gene Expression Market (2018-2034) by End User
7.3.1 Market Overview
7.3.2 Drug Discovery & Development Centers
7.3.3 Diagnostic Laboratories
7.3.4 Academic Research Centers
8 Canada Gene Expression Market (218-2034)
8.1 Canada Gene Expression Market (2018-2034) by Technology
8.1.1 Market Overview
8.1.2 Polymerase Chain Reaction
8.1.3 Next Generation Sequencing
8.1.4 Microarrays
8.1.5 Northern Blotting
8.1.6 Others
8.2 Canada Gene Expression Market (2018-2034) by Product Type
8.2.1 Market Overview
8.2.2 Instruments
8.2.3 Reagents and Consumables
8.2.4 Services
8.2.5 Others
8.3 Canada Gene Expression Market (2018-2034) by End User
8.3.1 Market Overview
8.3.2 Drug Discovery & Development Centers
8.3.3 Diagnostic Laboratories
8.3.4 Academic Research Centers
9 Regulatory Framework
10 Patent Analysis
10.1 Analysis by Type of Patent
10.2 Analysis by Publication year
10.3 Analysis by Issuing Authority
10.4 Analysis by Patent Age
10.5 Analysis by CPC Analysis
10.6 Analysis by Patent Valuation
10.7 Analysis by Key Players
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 Thermo Fisher Scientific Inc.
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 GE Healthcare
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 QIAGEN N.V.
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Life Technologies
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 Agilent Technologies
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 PerkinElmer
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 Bio-Rad Laboratories
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 Roche Diagnostics
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 Oxford Gene Technology
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic Reach and Achievements
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
13.11 Luminex Corporation
13.11.1 Financial Analysis
13.11.2 Product Portfolio
13.11.3 Demographic Reach and Achievements
13.11.4 Mergers and Acquisitions
13.11.5 Certifications
14 North America Gene Expression Market - Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security